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lower at 5140 m (P = 0.070), compared with baseline. Des-
acylated ghrelin concentrations did not significantly change 
during the trek (P  =  0.177). Total ghrelin concentrations 
decreased from baseline to 4600 m (P = 0.045). Skinfold 
thickness was lower at all points during the trek compared 
with baseline (P  ≤  0.001) and calf girth decreased incre-
mentally during the trek (P = 0.010).
Conclusions Changes in plasma acylated and total ghrelin 
concentrations may contribute to the suppression of appe-
tite and energy intake at altitude, but differences in the time 
course of these responses suggest that additional factors 
are also involved. Interventions are required to maintain 
appetite and energy balance during trekking at terrestrial 
altitudes.
Keywords Ghrelin · Hypoxia · Altitude-induced 
anorexia · Terrestrial altitude
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Abstract 
Purpose Circulating acylated ghrelin concentrations are 
associated with altitude-induced anorexia in laboratory 
environments, but have never been measured at terrestrial 
altitude. This study examined time course changes in appe-
tite, energy intake, body composition, and ghrelin constitu-
ents during a high-altitude trek.
Methods Twelve participants [age: 28(4) years, BMI 
23.0(2.1) kg m−2] completed a 14-day trek in the Himala-
yas. Energy intake, appetite perceptions, body composition, 
and circulating acylated, des-acylated, and total ghrelin 
concentrations were assessed at baseline (113  m, 12  days 
prior to departure) and at three fixed research camps during 
the trek (3619 m, day 7; 4600 m, day 10; 5140 m, day 12).
Results Relative to baseline, energy intake was lower at 
3619 m (P = 0.038) and 5140 m (P = 0.016) and tended 
to be lower at 4600  m (P  =  0.056). Appetite perceptions 
were lower at 5140  m (P  =  0.027) compared with base-
line. Acylated ghrelin concentrations were lower at 3619 m 
(P  =  0.046) and 4600  m (P  =  0.038), and tended to be 
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Introduction
Acute exposure to hypoxic environments has been demon-
strated to suppress appetite and energy intake (Armellini et al. 
1997; Matu et al. 2017; Wasse et al. 2012; Westerterp et al. 
2000). This effect appears to be maintained during prolonged 
sojourns to high altitude, which results in significant decreases 
in body mass, of which greater than 50% is from fat-free mass 
(Rose et  al. 1988; Sergi et  al. 2010). These declines in lean 
mass will likely lead to a drop in physical capabilities at alti-
tude (Sergi et al. 2010), which can have deleterious implica-
tions for individuals ascending to high altitude. A better under-
standing of the time course of these changes during a trek, as 
well as the mechanisms involved, is required to develop guid-
ance for those travelling to high altitudes.
Over the past 20 years, changes in the circulating con-
centrations of gastrointestinal hormones and leptin have 
been implicated as potential mechanisms for the alterations 
in appetite and energy intake at altitude. However, although 
several hormones such as pancreatic polypeptide (Riepl 
et al. 2012), leptin (Sierra-Johnson et al. 2008), glucagon-
like-peptide-1 (Snyder et al. 2008), and total ghrelin (Benso 
et al. 2007; Riepl et al. 2012; Shukla et al. 2005) have been 
measured in response to terrestrial altitude exposure, the 
findings remain equivocal. One major limitation of the cur-
rent research is the measurement of total ghrelin concen-
trations at altitude, rather than the constituent components 
of acylated and des-acylated ghrelin which have opposing 
effects on appetite regulation (Fernandez et al. 2016). The 
differentiation of ghrelin constituents in response to ter-
restrial altitude is imperative as acylated ghrelin has been 
found to be particularly responsive to hypoxic exposure in 
a laboratory environment with decreases in this hormone 
correlated with a reduction in appetite (Bailey et al. 2015) 
and energy intake (Wasse et al. 2012). Furthermore, recent 
evidence suggests that des-acylated ghrelin may inhibit 
the orexigenic effects of acylated ghrelin (Fernandez et al. 
2016), which further emphasises the need to measure both 
hormones as well as the ratio between the two (Al Massadi 
et al. 2014). It seems feasible that the measurement of total 
ghrelin in previous research (Benso et  al. 2007; Debevec 
et al. 2014; Riepl et al. 2012) may have masked changes in 
acylated and des-acylated ghrelin, which may explain the 
lack of association between changes in appetite and circu-
lating ghrelin concentrations at altitude.
Although circulating total ghrelin concentrations have 
been extensively investigated in response to hypoxic expo-
sure (Benso et al. 2007; Debevec et al. 2014, 2016; Mek-
javic et  al. 2016; Riepl et  al. 2012; Shukla et  al. 2005), 
the investigation of acylated ghrelin is currently limited 
to four studies, all of which lasted for ≤7  h and were all 
conducted in normobaric environments (Bailey et al. 2015; 
Matu et al. 2017; Morishima and Goto 2016; Wasse et al. 
2012). Although laboratory studies of this nature are valu-
able to gain greater mechanistic understanding, further 
field studies are required to assess the combined effects of 
trekking, gradual ascent, and other environmental stimuli 
such as cold exposure which occur during real life ascent 
to high altitude. The measurement of acylated and des-
acylated ghrelin during ascent to terrestrial altitude is vital 
to understand the changes that occur during a real-world 
environment and the importance of these changes as a basis 
for the development of future interventions. The lack of 
investigation into the constituents of total ghrelin to date 
is likely due to the complexities of the necessary chemical 
preparation required to prevent the degradation of the ana-
lytes (Hosoda et al. 2004), which is particularly difficult to 
achieve in an extreme field environment.
The purpose of this study was to investigate the effects 
of a high-altitude trek to 5300 m on appetite, energy intake, 
and body composition responses in healthy men and 
women, with a further focus on circulating acylated and 
des-acylated ghrelin concentrations as mechanistic vari-
ables. These data provide novel insights into the time course 
of changes in appetite, energy intake, and body composition 
during a real-life ascent to high altitude. This study also pro-
vides a better understanding of the mechanisms responsible 
for altitude-induced anorexia, representing the first investi-
gation of acylated ghrelin and des-acylated ghrelin at terres-
trial altitude. We hypothesised that exposure to increasingly 
high altitudes would suppress appetite, circulating acylated 
ghrelin concentrations and energy intake, which would be 
associated with a reduction in lean and total body mass.
Methods
Participants
This study was conducted according to the guidelines 
laid down in the Declaration of Helsinki and all proce-
dures were approved by the Ethics Advisory Committee 
at Leeds Beckett University and the Ministry of Defence 
Research Ethics Committee (MoDREC; protocol num-
ber 624). Twelve members (nine male and three female) 
of the British Military volunteered to participate in this 
study. Informed consent was obtained from all participants 
included in the study. All participants were non-smokers, 
had no known disease, allergies, or intolerances, and had 
not been to an altitude over 1000 m for at least 3 months. 
All participants were physically fit and could run 2.4 km on 
a treadmill at a 2% gradient in under 13 min 37 s in accord-
ance with military requirements. The physical character-
istics of participants [mean (SD)] were as follows: age 28 
(4) years, body mass 71.3 (10.3) kg, and body mass index 
(BMI) 23.0 (2.1) kg m−2.
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Study design
This study represents part of the ‘British Services Dhaula-
giri Medical Research Expedition’ which took place in 
March–May 2016 (Mellor et al. 2017). In April 2016, par-
ticipants in the present study travelled from the UK to Nepal 
and completed a 14-day trek around the Dhaulagiri circuit in 
the Himalayas. Travel from the UK to Nepal lasted for 1 day 
and participants were in Nepal for 3 days prior to starting 
the trek. The trek commenced from Darbang (~1100  m), 
peaked on day 11 at the French Pass (~5300 m), and ended 
on day 14 at Marpha (~2700 m). Pre-planned rest days were 
included at fixed camps at 3619 m (Camp 1; day 7), 4600 m 
(Camp 2; day 10), and 5140 m (Camp 3; day 12). Partici-
pants walked a mean distance of 8.2 km day−1 with a mean 
elevation gain of 471  m  day−1 whilst carrying a day pack 
weighing ~5 kg. Further information about the ascent pro-
file and trek characteristics has been published elsewhere 
(Mellor et al. 2017). Data collection took place at baseline 
(113 m; 12 days prior to departure from the UK) and at each 
fixed camp. On the day preceding data collection at camp 1, 
camp 2, and camp 3 participants walked 4.3, 4.3, and 9.1 km 
and gained an elevation of 512, 528, and 540  m, respec-
tively. All trekking on these days was completed by 5 pm. 
All participants wore the same type of clothing throughout 
the trek and experienced the same degree of cold exposure. 
Baseline measurements were collected in the laboratories 
at Leeds Beckett University and the measures at each camp 
were collected in a designated research tent. At the time 
data were collected, ambient temperatures in the laboratory 
and research tents were 19.8, 4.9, 1.2, and −6.4 °C at base-
line, 3619, 4600, and 5140 m, respectively. All participants 
remained rested on the day of testing. Participants were 
staggered for the collection of all measurements between 7 
am and 10 am, with each participant having their measures 
taken at a consistent time on all occasions and after an over-
night fast of at least 10 h.
Food provision
Throughout the trek, all foods and fluids were available 
ad  libitum, and were provided by Nepalese cooks and 
staff who accompanied the trekking team. Typical foods 
offered at each meal were as follows: breakfast—cere-
als, porridge, omelette, and pancakes; lunch—noodles, 
meats, soup, beans, vegetables, and fruit; dinner—curry, 
pasta, pizza, potatoes, dumplings, cheese, and vegetables; 
and snacks—chocolate bars, biscuits, cake, and fruit. At 
all meals, participants were given more than one option 
and thus could decide what they wanted to eat. The mean 
(SD) macronutrient composition of the food consumed 
during the trek was 49.0 (6.6) % carbohydrate, 36.3 (6.2) 
% fat, and 14.7 (2.6) % protein, respectively.
Food intake
Energy intake was assessed at baseline via a 24-h dietary 
recall interview by an experienced researcher (Academic 
Associate of the Sport and Exercise Nutrition Register) 
using the multiple-pass approach (Guenther et  al. 1997). 
In addition to collecting dietary intake information, this 
approach was used to demonstrate the level of detail 
required from the participants when completing a food 
diary during the trek. All participants completed a food 
diary on the day preceding each fixed camp and this pro-
cess was monitored and verified by the same experienced 
researcher throughout the trek. Although there are acknowl-
edged limitations of self-reported dietary intake methods 
(Hill and Davies 2001), the oversight of food diaries by the 
researcher present on the trek ensured accurate comple-
tion of all food diaries. Food intake was monitored during 
the day before each fixed camp to consider acute dietary 
changes when interpreting the data for fasted appetite rat-
ings and blood samples at the fixed camps. The palatability 
of each meal consumed was measured using 100 mm visual 
analogue scales (VAS) with the anchors “the worst taste 
that I have ever experienced” and “the best taste that I have 
ever experienced” at each end of the scale. A mean palat-
ability score was calculated for each day to control for any 
influence of palatability on food consumption.
Appetite
Appetite perceptions were measured after an overnight fast 
at baseline and upon waking at each fixed camp using vali-
dated 100  mm VAS for hunger, satisfaction, fullness, and 
prospective food consumption (PFC) (Flint et  al. 2000). 
Using these scales, a composite appetite score (CAS) 
was calculated using the following formula: composite 
appetite score  =  ([hunger  +  prospective food consump-
tion + (100−fullness) + (100−satisfaction)]/4) (Stubbs et al. 
2000). A higher value is associated with a greater appetite 
sensation and subsequently a stronger motivation to eat. In 
addition, the extent to which participants desired sweet, salty, 
savoury, and fatty foods was assessed using VAS anchored at 
each end with “yes, very much”, and “no, not at all”.
Acute mountain sickness, oxygen saturation, and rating 
of perceived exertion
Acute mountain sickness (AMS) was assessed every morn-
ing and evening using the Lake Louise AMS (LLS) score 
(Roach et al. 1993); mild AMS was defined as LLS of ≥3 
in the presence of a headache and severe AMS was defined 
as LLS of ≥6 in the presence of a headache. Arterial oxy-
gen saturations  (SpO2) were measured via a fingertip pulse 
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oximeter (Nellcor™ PM10N; Medtronic, Minneapolis, 
MN) every morning and evening, whilst the participants 
were resting in a seated position. Rating of perceived exer-
tion (RPE) (Borg 1982) was recorded as the hardest exer-
tion experienced during the day of trekking preceding each 
fixed camp, as used previously in similar environments 
(Mellor et al. 2014).
Body composition
Participants were weighed at baseline and each fixed camp 
in a fasted state whilst wearing minimal clothing and no 
footwear. A portable multicomponent force plate (Kistler, 
Switzerland) was used and was stabilised on the mountain 
using specialised levelling feet (JVD Design & Automa-
tion Ltd, Leeds, UK). Skinfolds of the triceps, subscapu-
lar, biceps, iliac crest, supraspinale, abdominal, front thigh, 
and medial calf were measured using calibrated Harpenden 
callipers (John Bull, British Indicators, West Sussex, UK) 
to the nearest 0.1  mm. The sum of skinfolds was calcu-
lated by the addition of each of the eight skinfold values in 
mm. Girth measurements of the waist and calf, as well as 
the upper arm in a relaxed and flexed state, were obtained 
using a steel anthropometric tape (Lufkin W606PM, 
Cooper Hand Tools, Tyne & Wear, UK) to the nearest 
1 mm. All anthropometric assessments were conducted by 
one researcher who was trained by an individual accred-
ited by the International Society for the Advancement of 
Kinanthropometry (ISAK). All measures were conducted 
in duplicate and in accordance with ISAK guidelines on the 
right side of the body. The coefficient of variation for skin-
folds and girths was 2.2 and 0.4%, respectively.
Blood sampling
Venous blood samples were obtained from an antecubital 
vein via venepuncture using a 21-gauge butterfly needle 
(Safety-Lok™; BD, Oxford, UK). Samples were collected 
at baseline and at all research camps with participants in 
a fasted state. One 4.9  mL pre-cooled EDTA monovette 
(Sarstedt, Leicester, UK) was used to obtain samples for 
the determination of plasma  acylated and des-acylated 
ghrelin concentrations. Monovettes were pre-treated on the 
morning of testing, to prevent the degradation of acylated 
ghrelin, with 50  µL of a solution containing p-hydrox-
ymercuribenzoic acid, potassium phosphate buffer, and 
sodium hydroxide (Hosoda et al. 2004). Immediately after 
filling, the tube was spun at 1500×g for 10 min in a cen-
trifuge (CompactStar CS4, VWR). Subsequently, 1 mL of 
plasma was mixed with 100 µL of 1 M hydrochloric acid. 
This solution was then immediately frozen at either −20 °C 
in a freezer (for baseline measurements) or within a dry 
shipper containing liquid nitrogen at <−80  °C (at each 
fixed camp) before being transferred to a −80  °C freezer 
at the university and stored until analysis. Plasma volume 
changes as a result of altitude exposure were not assessed 
during the trek, because it is the absolute plasma hormonal 
concentrations that would determine the body’s response at 
that specific time (Kargotich et al. 1998). However, to pre-
vent any extraneous influences from postural changes, all 
blood samples were collected after the participant had been 
seated for at least 5 min (Fawcett and Wynn 1960).
Blood analyses
Commercially available enzyme immunoassays were 
used to determine plasma concentrations of acylated and 
des-acylated ghrelin (SPI BIO, Montigny Le Bretonneux, 
France). To eliminate interassay variation, all samples from 
each participant were analysed on the same plate. In addi-
tion, all samples were analysed in duplicate and on the 
same day. The within batch coefficients of variation were 
2.5% for acylated ghrelin and 2.4% for des-acylated ghre-
lin. Total ghrelin was computed via the addition of acylated 
and des-acylated ghrelin concentrations. The ratio between 
acylated ghrelin and des-acylated ghrelin concentrations 
(AG:DG) was calculated as acylated ghrelin divided by 
des-acylated ghrelin, as previously described (Delhanty 
et al. 2015).
Statistical analysis
Data are expressed as mean (SD) in text and tables and 
mean (SE) in figures to avoid distortion of the graphs. Diet 
records were inputted into the Nutritics dietary analysis 
software (v1.8 for Windows; Nutritics, Dublin) to assess 
energy intake. All data were analysed using IBM SPSS 
statistics (v22.0 for Windows; SPSS, Chicago, IL). One-
way repeated measures analysis of variance (ANOVA) was 
used to assess altitude-based differences in  SpO2, AMS 
scores, RPE scores, body composition measures, appetite 
perceptions, energy intake, fluid intake, and plasma ghre-
lin concentrations. Significant effects were further explored 
using Student’s paired t tests. Effect sizes are presented as 
Cohen’s d and interpreted as ≤0.2 trivial, >0.2 small, >0.6 
moderate, >1.2 large, >2 very large, and >4 extremely 
large (Hopkins 2004). The Pearson product moment cor-
relation coefficient was used to investigate relationships 
between variables at each altitude. The exclusion of partici-
pants reporting AMS did not alter the interpretation of the 
findings; subsequently, all participants were included in the 
data analysis. Based on evidence that males and females 
exhibit similar appetite, energy intake, and gut hormone 
responses to exercise- and diet-induced energy deficits 
(Alajmi et  al. 2016), data from both genders were com-
bined for analyses. The sample size used within this study 
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was deemed sufficient to detect a significant difference in 
energy intake between altitudes. The anticipated effect size 
for a difference in energy intake was based on a similar pre-
vious study which investigated energy intake in individuals 
climbing at approximately 4500 m for 16 days (Armellini 
et  al. 1997). Based on the effect size and an alpha value 
of 5%, a sample size of 12 participants would generate a 
power >95%. Calculations were performed using G*power 
(v3 for Windows; Düsseldorf) (Faul et al. 2007).
Results
Measurements of  SpO2, AMS, RPE, body composition, 
fluid intake, and energy intake were successfully obtained 
from all 12 participants. One male participant withdrew 
consent for blood sampling at the research camps dur-
ing the trek and one male participant did not complete the 
appetite perception measurements during the trek. There-
fore, data are presented for 11 participants for plasma hor-
mone concentrations and appetite perceptions.
Oxygen saturations, acute mountain sickness, 
and rating of perceived exertion
One-way ANOVA revealed a main effect of altitude for  SpO2 
(P  <  0.001). Post-hoc analysis demonstrated lower  SpO2 
at each fixed camp compared with the previous location 
[baseline: 98.4 (0.9)  %; 3619  m: 92.4 (2.5) %, P  <  0.001, 
d  =  3.19; 4600  m: 83.5 (4.1) %, P  <  0.001, d  =  2.62; 
5140  m: 79.8 (5.6) %, P  =  0.007, d  =  0.75]. A positive 
diagnosis of mild AMS was reported in 50% of participants 
at some point during the trek. The first incidence of AMS 
occurred on the 8th day of the trek (the day after the first 
rest day; 4072 m). Incidence of AMS at the four fixed loca-
tions was as follows: baseline: zero participants; 3619  m: 
zero participants; 4600 m: two participants; and 5140 m: two 
participants. One-way ANOVA revealed a significant effect 
of altitude for RPE (P < 0.001). Relative to 3619 m [11.8 
(1.5)], RPE was significantly higher at 4600 m [13.3 (1.5), 
P = 0.009, d = 1.01] and relative to 4600 m RPE was sig-
nificantly higher at 5140 m [16.5 (2.5), P = 0.003, d = 1.58].
Energy and fluid intake
One-way ANOVA revealed a significant effect of altitude 
for energy intake (P = 0.015). Relative to baseline, energy 
intake was significantly lower at 3619  m (P  =  0.038, 
d = 1.05) and 5140 m (P = 0.016, d = 1.00) and tended 
to be lower at 4600 m (P = 0.056, d = 0.82). There were 
no differences observed between research camps during the 
trek (all P ≥ 0.333, d ≤ 0.22) (Fig. 1a).
Fig. 1  Energy intake (a), palatability score (b) and composite appe-
tite score (c) at baseline, 3619, 4600, and 5140 m. * significant differ-
ence from baseline. ‡ significant difference between 4600 and 5140 m. 
§ significant difference between 3619 and 5140 m (one-way ANOVA; 
P < 0.05 after post-hoc analyses). Values are mean (SE), N = 12 for 
energy intake and palatability, N = 11 for composite appetite score
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One-way ANOVA revealed a main effect of altitude 
for fluid intake (P  =  0.029). Relative to baseline (2769 
(1156) mL day−1), fluid intake was significantly higher at 
3619 m [4438 (1847) mL day−1, P = 0.008, d = 1.08] and 
4600 m [4236 (2120) mL day−1, P = 0.027, d = 0.86], but 
not significantly higher at 5140 m [3645 (2026) mL day−1, 
P = 0.126, d = 0.53]. There were no differences observed 
between camps (all P ≥ 0.266, d ≤ 0.29).
One-way ANOVA revealed a main effect of altitude for 
the daily palatability of food consumed (P = 0.018). Rela-
tive to baseline, palatability was significantly higher at 
3619 m (P = 0.030, d = 1.17). However, palatability was 
not different at 4600 m (P = 0.147, d = 0.66) or 5140 m 
(P = 0.509, d = 0.32) compared with baseline. Palatability 
was significantly lower at 5140 m compared with 3619 m 
(P = 0.020, d = 0.97) and 4600 m (P = 0.013, d = 0.71) 
(Fig. 1b).
One-way ANOVA revealed a main effect of altitude on 
the desire to eat salty (P = 0.025) and savoury (P < 0.001) 
foods, but not sweet (P = 0.604) or fatty (P = 0.354) foods. 
Relative to baseline [67 (12) mm], the desire to eat salty 
foods was significantly lower at 3619  m [41 (23) mm, 
P = 0.018, d = 1.42] and 5140 m [39 (27) mm, P = 0.024, 
d = 1.38] and also tended to be lower at 4600 m [45 (27) 
mm, P  =  0.066, d  =  1.09]. There were no differences 
observed between camps (all P  ≥  0.159, d  ≤  0.22). The 
desire to eat savoury foods was significantly increased at 
3619 m [70 (13) mm, P < 0.001, d = 2.41], 4600 m [67 
(15) mm, P < 0.001, d = 2.03], and 5140 m [53 (19) mm, 
P = 0.011, d = 1.08) compared with baseline [33 (18) mm]. 
In addition, the desire to eat savoury foods reduced signifi-
cantly from 4600 to 5140 m (P = 0.026, d = 0.79) with no 
difference observed between 3619 and 4600 m (P = 0.516, 
d = 0.23).
Appetite perceptions
One-way ANOVA revealed a main effect of altitude for 
CAS (P  =  0.005). Post-hoc analysis revealed that CAS 
was significantly lower at 5140  m compared with base-
line (P = 0.027, d = 1.07), 3619 m (P = 0.005, d = 1.19), 
and 4600  m (P  =  0.05, d  =  0.69). No other differences 
were observed between altitudes (all P ≥ 0.116, d ≤ 0.48) 
(Fig. 1c).
Plasma acylated and des‑acylated ghrelin 
concentrations
One-way ANOVA revealed a significant effect of altitude 
for plasma  acylated ghrelin concentrations (P  =  0.048; 
Fig.  2a), plasma total ghrelin concentrations (P  =  0.047; 
Fig. 2d), and the AG:DG ratio (P = 0.046; Fig. 2c). A main 
Fig. 2  Acylated ghrelin (a), 
des-acylated ghrelin (b), 
AG:DG ratio (c), and total 
ghrelin (d) concentrations 
at baseline, 3619, 4600, and 
5140 m. * significant differ-
ence from baseline (one-way 
ANOVA; P < 0.05 after post-
hoc analyses). Values are mean 
(SE), N = 11
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effect of altitude was not detected for plasma des-acylated 
ghrelin concentrations (P = 0.177; Fig. 2b).
Relative to baseline, plasma  acylated ghrelin concen-
trations were significantly lower at 3619  m (P  =  0.046, 
d = 0.25) and 4600 m (P = 0.038, d = 0.29), and tended 
to be lower at 5140 m (P = 0.070, d = 0.28). There were 
no differences observed between camps (all P  ≥  0.512, 
d ≤ 0.04; Fig. 2a). Plasma AG:DG ratio decreased signifi-
cantly from baseline to 3619 m (P = 0.034, d = 0.37), and 
tended to be lower than baseline at 4600  m (P  =  0.069, 
d = 0.23) and 5140 m (P = 0.070, d = 0.25). There were 
no differences observed between camps (all P  ≥  0.362, 
d  ≤  0.15) (Fig.  2c). Plasma total ghrelin concentra-
tions decreased significantly from baseline to 4600  m 
(P  =  0.045, d  =  0.36); however, no other significant dif-
ferences were observed between altitudes (all P  ≥  0.111, 
d ≤ 0.31) (Fig. 2d).
Body composition
One-way ANOVA revealed a significant effect of altitude 
for body mass (P < 0.001), sum of skinfolds (P < 0.001), 
calf girth (P  =  0.010), waist girth (P  =  0.016), and 
relaxed arm girth (P  =  0.029), with no significant dif-
ferences observed for flexed arm girth (P  =  0.173) 
(Table 1).
Body mass increased from baseline to 3619  m 
(P  =  0.002, d  =  0.18), decreased between 3619 and 
4600  m (P  <  0.001, d  =  0.22) and did not change 
between 4600 and 5140 m (P = 0.415, d = 0.03). Sum 
of skinfolds was lower at 3619 m (P = 0.001, d = 0.30), 
4600 m (P < 0.001, d = 0.34), and 5140 m (P = 0.001, 
d  =  0.24) compared with baseline. There were no sig-
nificant differences observed between each of the camps 
during the trek (all P ≥ 0.116, d ≤ 0.09).
Calf girth did not differ significantly between baseline 
and 3619  m (P  =  0.127, d  =  0.30), however, was sig-
nificantly decreased at 4600 m (P = 0.039, d = 0.44) and 
5140 m (P = 0.008, d = 0.60) compared with baseline. 
Calf girth was also significantly lower at 4600  m com-
pared with 3619 m (P = 0.031, d = 0.14), and tended to 
be lower at 5140 m compared with 4600 m (P = 0.069, 
d  =  0.14). Waist girth did not differ between baseline 
and any of the three camps (all P  ≥  0.122, d  ≤  0.15), 
however, was significantly lower at 5140  m than 
3619  m (P  <  0.001, d  =  0.29) and 4600  m (P  =  0.04, 
d = 0.13). Relaxed arm girth was significantly lower at 
3619 m (P = 0.022, d = 0.30) and 4600 m (P = 0.047, 
d = 0.23) and tended to be lower at 5140 m (P = 0.073, 
d = 0.20) compared with baseline. There was a signifi-
cant increase in relaxed arm girth between 3619 and 
5140 m (P = 0.047, d = 0.10), with no other differences 
observed between camps (all P ≥ 0.191, d ≤ 0.07).
Correlations
There were no correlations observed at any altitude between 
energy intake and CAS (all r  ≤  0.311, P  ≥  0.352). At 
3619 m, CAS tended to be associated with plasma acylated 
ghrelin (r = 0.603, P = 0.065) and total ghrelin (r = 0.626, 
P = 0.053) concentrations. In addition, at 3619 m, energy 
intake was significantly correlated with des-acylated ghre-
lin concentrations (r = 0.686, P = 0.029). At 4600 m, CAS 
was significantly correlated with acylated ghrelin con-
centrations (r  =  0.633, P  =  0.049) and the AG:DG ratio 
(r = 0.667, P = 0.035). There were no other significant cor-
relations observed between any variable, at any altitude (all 
r ≤ 0.511, P ≥ 0.108).
Discussion
This study presents an assessment of the changes in appe-
tite perceptions, energy intake, body composition, and 
ghrelin constituents throughout a trek to high terrestrial 
altitude. The findings demonstrate a reduction in energy 
Table 1  Body composition 
measurements at baseline, 3619, 
4600, and 5140 m
Values are mean (SD), N = 12
* Significant difference from baseline
†  Significant difference between 3619 and 4600 m
‡  Significant difference between 4600 and 5140 m
§  Significant difference between 3619 and 5140 m (one-way ANOVA; P < 0.05 after post-hoc analyses)
Baseline 3619 m 4600 m 5140 m
Body mass (kg) 71.3 (10.3) 73.1 (10.2)* 70.8 (10.7)† 71.1 (10.0)§
Sum of 8 Skinfolds (mm) 81.2 (23.7) 74.2 (22.3)* 73.5 (21.7)* 75.5 (23.9)*
Calf girth (cm) 38.1 (1.9) 37.5 (2.1) 37.2 (2.2)*,† 36.9 (2.1)*,§
Waist girth (cm) 77.5 (6.6) 78.2 (5.5) 77.3 (5.5) 76.6 (5.4)‡,§
Relaxed arm girth (cm) 29.5 (3.0) 28.6 (3.0)* 28.8 (3.1)* 28.9 (2.9)§
Flexed arm girth (cm) 30.6 (3.2) 30.2 (3.2) 30.1 (3.2) 30.1 (3.1)
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intake and skinfold thickness during the trek, with a pro-
gressive reduction in appetite at increasing altitudes. This 
study provides the first investigation of acylated ghrelin and 
des-acylated ghrelin concentrations at terrestrial altitude 
and demonstrates a suppression of acylated- but not des-
acylated ghrelin during the trek. These findings highlight 
the importance of measuring ghrelin constituents in addi-
tion to total ghrelin concentrations as small fluctuations in 
des-acylated ghrelin may mask changes in acylated ghrelin 
if only total ghrelin was to be measured. This phenomenon 
would have occurred at 3619  m in the present study as 
observed by a significant decrease in acylated ghrelin lev-
els in the absence of any significant changes in des-acylated 
and total ghrelin concentrations. The findings from this 
study also demonstrate the need for interventions to main-
tain appetite during exposure to terrestrial altitudes, par-
ticularly above 4600 m.
In the present study, energy intake was reduced by 27% 
(9326 kJ) at 3619 m, 22% (9886 kJ) at 4600 m, and 27% 
(9238 kJ) at 5140 m compared with baseline, which sub-
stantiates previous findings at similar altitudes. Armellini 
et al. (1997) observed a 29% decrease in energy intake in 
individuals climbing at approximately 4500 m for 16 days, 
whilst Aeberli et al. (2013) demonstrated a 32% reduction 
in energy intake 2 days after rapid ascent to 4559 m. One 
study, however, found that energy intake, as well as fat 
and muscle mass, could be maintained up to an altitude of 
5050 m when a wide choice of palatable foods was avail-
able in a comfortable setting (Kayser et  al. 1993). It may 
therefore be argued that the reduction in energy intake in 
the present study was caused by a lack of food availabil-
ity and reduced palatability of food whilst trekking in a 
foreign country. However, at 3619  m, energy intake was 
significantly suppressed compared with baseline, whilst 
food was widely available and the mean palatability of 
the food consumed was significantly higher than baseline. 
These findings agree with those of Rose et al. (1988) who 
found a significant reduction in ad  libitum energy intake 
during a simulated ascent of Mount Everest, despite a 
variety of palatable foods being available. Despite the 
reduction in energy intake, fasting appetite perceptions 
were similar between baseline and 3619  m, which sug-
gest a greater satiating effect of the energy consumed. This 
response was maintained at 4600  m, but appetite percep-
tions decreased significantly at 5140  m despite consistent 
food intake. Observations during the trek suggested that 
participants were consciously trying to maintain energy 
intakes throughout the trek in an attempt to maintain physi-
cal performance. This would support the observation that 
food intake was similar between the three camps, but that 
appetite perceptions and the desire for foods decreased 
with increasing altitude. This mismatch between appetite 
perceptions and energy intake is further supported by the 
lack of correlation between the two variables at each alti-
tude. The reduced palatability of the foods consumed at 
5140 m also supports a reduction in appetite, and occurred 
despite the same ad libitum food provision throughout the 
trek. This effect accords with the findings from previous 
animal studies which suggest that hypoxia degrades the 
taste of food (Ettinger and Staddon 1982). Considering the 
significant suppression of appetite at 5140 m, it is unclear 
whether food intakes could continue to be maintained over 
a more prolonged period and targeted interventions to bet-
ter maintain appetite above 4600 m may be beneficial.
From a mechanistic perspective, trekking to high alti-
tude induced a suppression of acylated but not des-acylated 
ghrelin concentrations, which resulted in a suppression 
of total ghrelin levels and the AG:DG ratio. However, at 
5140 m, the only altitude in which CAS was significantly 
suppressed, no correlations were observed between any 
blood marker and CAS or energy intake. These findings 
suggest that appetite regulation during high-altitude trek-
king may be influenced by other hormonal [e.g., leptin, 
glucagon-like peptide-1, and peptide YY (Debevec 2017)] 
and non-hormonal [e.g., taste degradation (Ettinger and 
Staddon 1982) potentially altering food reward (Berthoud 
2006)] factors. Appetite regulation is a complex multifac-
eted system which involves the integration of a wide range 
of neuroendocrine and psychological factors (Murphy and 
Bloom 2006). Subsequently, appetite suppression at alti-
tude is unlikely to be solely explained by the measurement 
of a single hormone. However, a better understanding of 
the neuroendocrine responses to high-altitude trekking 
could be beneficial in the design of interventions to mini-
mise appetite suppression at altitude.
The reductions in fasted acylated and total ghrelin con-
centrations, the day after significantly reduced energy 
intakes compared with baseline measurements, are particu-
larly interesting considering the evidence that ghrelin levels 
and appetite perceptions increase in response to reduced 
food intake at sea level (Alajmi et al. 2016). Furthermore, 
acylated ghrelin levels remained depressed during the trek 
despite reductions in body mass between 3619 and 4600 m 
and the established inverse relationship between body mass 
and ghrelin concentrations at sea level (Chen et  al. 2009; 
Shiiya et  al. 2002). These observations suggest that the 
reductions in acylated and total ghrelin during this study 
were genuine effects of high-altitude exposure rather than 
being secondary to any changes in food intake or body 
composition. Although these changes in ghrelin were small, 
they appear to be physiologically relevant as changes of 
this magnitude have previously been associated with reduc-
tions in appetite and energy intake in a laboratory environ-
ment (Bailey et  al. 2015; Wasse et  al. 2012). It would be 
beneficial for future research to attempt to increase circu-
lating plasma acylated ghrelin concentrations at altitude, to 
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quantify these effects on appetite responses. Potential meth-
ods of accomplishing this include ghrelin infusion (Druce 
et  al. 2005) or dietary interventions to manipulate ghrelin 
constituents [e.g., increased medium chain triglyceride 
intake as a substrate for ghrelin acylation (Kawai et  al. 
2017; Nishi et al. 2005)].
The reasons for the observed suppression of acylated 
ghrelin at altitude are unclear. However, considering the 
lack of change in total ghrelin levels at 3619 m, it seems 
plausible that the post-translational acylation of ghrelin 
may have been inhibited during the early stages of the trek 
due to inhibited ghrelin-O-acyltransferase (GOAT) activ-
ity or reduced availability of medium chain fatty acids as 
the substrate for acylation (Nishi et al. 2005). Alternatively, 
the reduction in both acylated ghrelin and total ghrelin at 
4600 m suggests inhibited secretion of ghrelin from the P/
D1 cells of the stomach (Kojima et al. 1999). A reduction 
in gut blood flow at altitude (Loshbaugh et  al. 2006) has 
also been proposed to reduce ghrelin concentrations (Wasse 
et  al. 2012); however, this concept has been disputed 
(Kalson et al. 2010; Mekjavic et al. 2016). The depression 
of acylated ghrelin levels prior to the depression of total 
ghrelin levels at the subsequent research camp suggests that 
acylated ghrelin may be a more sensitive measure of altered 
appetite signalling at altitude. Furthermore, the AG:DG 
ratio of >1 in the present study supports recent data that 
acylated ghrelin constitutes a much larger proportion of 
total ghrelin than previously thought (Delhanty et al. 2015) 
and demonstrates that preservation of this peptide can be 
achieved during field research in extreme environments.
In accordance with previous research, considerable 
changes in body composition were observed during the 
trek. This includes a mean reduction in body mass of 2.3 kg 
in the 3 days between 3619 and 4600 m, which was asso-
ciated with significant decreases in calf girth despite very 
high levels of physical activity (mean distance walked: 
8.8 km day−1, mean elevation gain: 491 m day−1). It seems 
likely that the reductions in body mass were not only 
caused by decreases in energy intake, but also by increases 
in energy expenditure due to the high-altitude environment 
and high physical activity levels. Such decreases in body 
and muscle mass have been observed in previous altitude 
research (Benso et al. 2007; Rose et al. 1988; Shukla et al. 
2005; Westerterp et  al. 2000) and it is likely that these 
losses would impair physical performance in these envi-
ronments (Sergi et al. 2010). The further reductions in calf 
girth between 3619 and 5140  m also align with previous 
research (Rose et al. 1988), but the reasons for this response 
are unknown. We speculate that an increase in protein 
degradation may have occurred due to increasing altitude 
exposure (Holm et  al. 2010). However, contrary to these 
changes in calf girth, an increase in relaxed arm girth was 
observed between 3619 and 5140 m. Although this increase 
was statistically significant, the absolute increase of 0.3 mm 
seems trivial. This may represent a compensatory response 
to the significant reduction in arm girth between baseline 
and 3619 m which is most likely due to atrophy caused by 
reduced activity of the arms during final preparations and 
low altitude trekking. Despite these insights into changes in 
body composition, it must be acknowledged that the base-
line measures were collected 12 days before departure from 
the UK, which may have confounded comparisons between 
baseline values and those obtained during the trek due to 
changes in body composition during the final preparations 
for the expedition. Potential increases in lean body mass 
from final preparations and reductions in body fat would 
support the observed increase in body mass at the first fixed 
camp and reduced skinfold values at all camps relative to 
baseline. At sea level, an increase in body mass would usu-
ally result in a reduction in acylated ghrelin concentrations 
(Chen et al. 2009), which accords with our findings at the 
first fixed camp. However, in the present study, body mass 
then significantly reduced at the second and third camps, 
without a subsequent increase in ghrelin. This suggests that 
changes in ghrelin were unlikely to be the result of fluctua-
tions in body mass during the trek and were more strongly 
mediated by high-altitude exposure.
Although the findings of the present study provide 
novel information regarding the appetite and metabolic 
responses during an incremental trekking ascent to high 
altitude, some notable limitations must be acknowledged. 
First, the current study design did not include a control 
group to separate the effects of trekking and high-altitude 
exposure. Therefore, it is not possible to conclude that the 
obtained results are a consequence of hypobaric hypoxia 
per se, but are a result of high-altitude trekking which com-
bines various environmental and psychological factors as 
well as demanding physical exercise. An example of this 
being that cold exposure may interfere with energy balance, 
potentially by increasing non-shivering thermogenesis 
(van der Lans et al. 2013). Although this limits interpreta-
tion of the influence of each of these factors individually, 
the study design allowed us to investigate the effects of a 
real-world gradual ascent to high altitude to understand the 
practical implications for high-altitude trekking. Second, it 
was not possible to standardise the trekking distance on the 
day preceding each fixed camp due to the extreme terrain 
and environment. The greater trekking distance performed 
on the day prior to the final research camp in combination 
with higher altitude exposure resulted in markedly higher 
RPE scores at 5140 m. However, although exercise-induced 
anorexia occurs acutely in response to strenuous exercise, 
tightly controlled laboratory studies suggest that this does 
not affect appetite perceptions and ghrelin concentrations 
during the next day (King et al. 2015). Therefore, the sup-
pression of appetite at 5140  m is unlikely to be due to 
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greater exertion during trekking on the previous day. Fur-
thermore, increased energy expenditure from the greater 
trekking distance and the continued suppression of energy 
intake suggests that participants would have been in their 
greatest energy deficit at the final research camp. This 
would be expected to increase appetite under sea-level con-
ditions (Alajmi et al. 2016) and provides further support for 
a genuine altitude-mediated suppression of appetite. Third, 
the current study did not assess hydration status during 
the trek; therefore, it is possible that the observed reduc-
tion in body mass could be partly attributed to dehydration. 
However, it should be noted that reductions in skinfold and 
girth measurements were observed during the trek which 
suggests that the changes in body mass were at least partly 
due to genuine reductions in fat mass and muscle mass. 
Although the estimation of body composition using skin-
fold and girth measurements contains limitations, this was 
deemed to be the most practical and achievable method of 
assessment considering the extreme research environment 
encountered in the present study. In addition, mean fluid 
intake on the day before each fixed camp was >3.6 L day−1 
which makes it unlikely that the participants experienced 
severe dehydration. It is not expected that the higher fluid 
intake during the trek, compared with baseline, would have 
influenced the measured ghrelin constituents given that 
gastric distension from water ingestion does not appear 
to influence plasma ghrelin concentrations (Tschop et  al. 
2000).
In conclusion, this study represents the first investiga-
tion of circulating ghrelin constituents in response to ter-
restrial altitude exposure and provides a time course of 
the changes in appetite, energy intake and body composi-
tion during gradual trekking ascent to high altitude. These 
findings demonstrate consistently reduced energy intake 
during high-altitude exposure and an incremental reduc-
tion in appetite perceptions with increasing altitude. These 
changes were associated with reductions in circulating con-
centrations of acylated and total ghrelin during the trek but 
differences in the time course of these responses suggests 
that additional factors are also involved. A negative energy 
balance during the trek caused reductions in body mass and 
lower body muscle mass which may have negative conse-
quences for physical performance. Future investigations are 
required to develop nutritional and/or physiological inter-
ventions to maintain appetite, energy intake, and muscle 
mass at altitude.
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